Your session is about to expire
← Back to Search
Anodal tDCS for Parkinson's Disease
Phase 2
Waitlist Available
Led By Brach Poston, Ph.D.
Research Sponsored by University of Nevada, Las Vegas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 day post, 2 weeks post, 4 weeks post
Awards & highlights
Summary
The goal of the proposed research is to determine the influence of transcranial direct current stimulation (tDCS) on long-term motor learning, transfer of motor learning, and cortical function in Parkinson's disease (PD). The project comprises a 2 week training study that will involve tDCS applied during two practice motor tasks with behavioral, clinical, and physiological evaluations at baseline as well as 1, 14 and 28 days following the 2 week training and stimulation period. The findings of the proposed studies should have significant clinical significance and applications to comprehensive intervention therapy development in the treatment of PD.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 1 day post, 2 weeks post, 4 weeks post
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 day post, 2 weeks post, 4 weeks post
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Force error in the precision grip task
Handwriting task performance
Secondary study objectives
Transfer of motor learning
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Anodal tDCSExperimental Treatment1 Intervention
Anodal tDCS will be applied in nine experimental sessions over a 2-week period.
Group II: SHAM tDCSPlacebo Group1 Intervention
SHAM tDCS will be applied in nine experimental sessions over a 2-week period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Anodal tDCS
2010
Completed Phase 2
~640
Find a Location
Who is running the clinical trial?
University of Nevada, Las VegasLead Sponsor
70 Previous Clinical Trials
13,948 Total Patients Enrolled
Brach Poston, Ph.D.Principal InvestigatorUniversity of Nevada, Las Vegas
Share this study with friends
Copy Link
Messenger